ANGPTL8 and metabolic syndrome: ANGPTL8’s role in lipid regulation suggests that a continuous rise in its levels can cause dyslipidemia and heightened insulin resistance, exacerbating metabolic stress and contributing to the onset of metabolic disorders such as T2D and DN.